Long-term open-label vebicorvir for chronic HBV infection: Safety and off-treatment responses.

Yuen MF, Fung S, Ma X, Nguyen TT, Hassanein T, Hann HW, Elkhashab M, Nahass RG, Park JS, Jacobson IM, Ayoub WS, Han SH, Gane EJ, Zomorodi K, Yan R, Ma J, Knox SJ, Stamm LM, Bonacini M, Weilert F, Ramji A, Bennett M, Ravendhran N, Chan S, Dieterich DT, Kwo PY, Schiff ER, Bae HS, Lalezari J, Agarwal K, Sulkowski MS

Open source

DOI
10.1016/j.jhepr.2023.100999
Published
2024 Apr
Container
JHEP reports : innovation in hepatology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jhepr.2023.100999,
  title = {Long-term open-label vebicorvir for chronic HBV infection: Safety and off-treatment responses.},
  author = {Yuen MF and Fung S and Ma X and Nguyen TT and Hassanein T and Hann HW and Elkhashab M and Nahass RG and Park JS and Jacobson IM and Ayoub WS and Han SH and Gane EJ and Zomorodi K and Yan R and Ma J and Knox SJ and Stamm LM and Bonacini M and Weilert F and Ramji A and Bennett M and Ravendhran N and Chan S and Dieterich DT and Kwo PY and Schiff ER and Bae HS and Lalezari J and Agarwal K and Sulkowski MS},
  year = {2024},
  journal = {JHEP reports : innovation in hepatology},
  doi = {10.1016/j.jhepr.2023.100999},
  url = {https://doi.org/10.1016/j.jhepr.2023.100999}
}

RIS

TY  - JOUR
TI  - Long-term open-label vebicorvir for chronic HBV infection: Safety and off-treatment responses.
AU  - Yuen MF
AU  - Fung S
AU  - Ma X
AU  - Nguyen TT
AU  - Hassanein T
AU  - Hann HW
AU  - Elkhashab M
AU  - Nahass RG
AU  - Park JS
AU  - Jacobson IM
AU  - Ayoub WS
AU  - Han SH
AU  - Gane EJ
AU  - Zomorodi K
AU  - Yan R
AU  - Ma J
AU  - Knox SJ
AU  - Stamm LM
AU  - Bonacini M
AU  - Weilert F
AU  - Ramji A
AU  - Bennett M
AU  - Ravendhran N
AU  - Chan S
AU  - Dieterich DT
AU  - Kwo PY
AU  - Schiff ER
AU  - Bae HS
AU  - Lalezari J
AU  - Agarwal K
AU  - Sulkowski MS
PY  - 2024
JO  - JHEP reports : innovation in hepatology
DO  - 10.1016/j.jhepr.2023.100999
UR  - https://doi.org/10.1016/j.jhepr.2023.100999
ER  - 

APA

MF, Y., S, F., X, M., TT, N., T, H., HW, H., M, E., RG, N., JS, P., IM, J., WS, A., SH, H., EJ, G., K, Z., R, Y., J, M., SJ, K., LM, S., M, B., F, W., A, R., M, B., N, R., S, C., DT, D., PY, K., ER, S., HS, B., J, L., K, A., & MS, S. (2024). Long-term open-label vebicorvir for chronic HBV infection: Safety and off-treatment responses.. JHEP reports : innovation in hepatology. https://doi.org/10.1016/j.jhepr.2023.100999

Source records